Publication | Closed Access

Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction

Metabolic SyndromeAgingCardiovascular DiseaseLongevityMyocardial InfarctionDiabetesPhysiologyPathologyHyperlipidemiaDiabetes MellitusMedicineAtherosclerosisDyslipidemiaSerum LevelsCoronary Heart DiseaseHealth Sciences